Earnings
-
Stryker stock falls on slower peripheral vascular, hip sales
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
By Elise Reuter • Sept. 10, 2026 -
Medtronic kicks off its fiscal year on a high note
The medical device maker grew revenue by double digits in its fiscal first quarter, following fourth-quarter growth of nearly 10%.
By Ricky Zipp • Sept. 1, 2026 -
MiniMed submits new patch pump for FDA clearance
The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.
By Elise Reuter • Sept. 1, 2026 -
Ortho firms unfazed by Medicare joint replacement changes
Shifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.
By Elise Reuter • Aug. 11, 2026 -
Zimmer Biomet sales force revamp going better than expected, CEO says
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
By Elise Reuter • Aug. 6, 2026 -
Stryker catching up on orders, manufacturing after cyberattack
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.
By Elise Reuter • July 31, 2026 -
Boston Scientific again cuts 2026 guidance
Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row.
By Ricky Zipp • July 29, 2026 -
Philips largely recoups struck-down Trump tariffs in Q2
The company recovered 186 million euros after it “largely completed the U.S. tariff refund process” in the quarter, CEO Roy Jakobs said on an earnings call.
By Nick Paul Taylor • July 28, 2026 -
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion
An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with moderate disease are expected to help the company maintain its momentum.
By Susan Kelly • July 24, 2026 -
Intuitive ties Q2 procedure softness to ACA subsidy expirations
Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.
By Susan Kelly • July 17, 2026 -
Abbott reports diagnostics growth since $21B Exact Sciences buy
The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.
By Elise Reuter • July 16, 2026 -
J&J misses company expectations for cardiovascular in Q2
Sales in Johnson & Johnson’s Abiomed business declined in the second quarter due to procedure volume pressures related to its Impella device.
By Ricky Zipp • July 15, 2026 -
Medtronic boosts revenue by nearly double digits in Q4
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
By Ricky Zipp • June 3, 2026 -
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
By Elise Reuter • June 3, 2026 -
Retrieved from Stryker on May 21, 2026
Stryker’s chief accounting officer to retire
William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.
By Elise Reuter • May 21, 2026 -
Carl Zeiss says restructuring could affect up to 1,000 jobs
A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.
By Susan Kelly • May 15, 2026 -
Mobia Medical CEO eyes large market for stroke rehab
With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.
By Elise Reuter • May 11, 2026 -
BD appoints Vitor Roque as permanent CFO
The company made Roque’s appointment permanent after considering external candidates for the role.
By Nick Paul Taylor • May 11, 2026 -
Tandem to file tubeless insulin pump with FDA this quarter
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.
By Elise Reuter • May 8, 2026 -
Insulet raises revenue expectations for 2026
CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.
By Elise Reuter • May 6, 2026 -
Stryker cyberattack ‘meaningfully’ impacted Q1
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
By Ricky Zipp • May 1, 2026 -
Zimmer Biomet CFO departs for new job
Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.
By Susan Kelly • April 28, 2026 -
Edwards raises 2026 forecast as TAVR sales surge
The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.
By Susan Kelly • April 24, 2026 -
Boston Scientific slashes 2026 guidance
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including electrophysiology and Watchman.
By Ricky Zipp • April 22, 2026 -
Intuitive Surgical lifts 2026 outlook for da Vinci robot procedure growth
The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.
By Susan Kelly • April 22, 2026